Sleep in Heart Failure

Progress in Cardiovascular Diseases

Volumn 51, Issue 4, 2009, Pages 339-349

  Naughton, Matthew T ^a,b   Lorenzi Filho, Geraldo ^c  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FUROSEMIDE; THEOPHYLLINE;

AROUSAL; ARTICLE; ATHEROSCLEROSIS; CENTRAL SLEEP APNEA SYNDROME; CHEYNE STOKES BREATHING; CLINICAL TRIAL; DIASTOLIC HEART FAILURE; HEART FAILURE; HEART FUNCTION; HEART OUTPUT; HUMAN; HYPERCAPNIA; HYPOXEMIA; LUNG EDEMA; LUNG MINUTE VOLUME; MORBIDITY; NONHUMAN; OXYGEN THERAPY; PACEMAKER; PATHOGENESIS; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; SLEEP; SLEEP APNEA SYNDROME; SUPINE POSITION; SURVIVAL RATE; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HEART FAILURE; THORAX PRESSURE; TREATMENT OUTCOME; VAGUS TONE; WEIGHT REDUCTION;

AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR AGENTS; CONTINUOUS POSITIVE AIRWAY PRESSURE; EVIDENCE-BASED MEDICINE; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; OXYGEN INHALATION THERAPY; PACEMAKER, ARTIFICIAL; PREVALENCE; SLEEP APNEA, CENTRAL; SLEEP APNEA, OBSTRUCTIVE; SUPINE POSITION; TREATMENT OUTCOME; VICTORIA;

EID: 57749101381     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2008.02.001     Document Type: Article

References (97)

1. Bonow R.O., Bennett S., Casey D.E., et al. ACC/AHA clinical performance measures for adults with chronic heart failure. JACC 46 (2005) 1144-1178
2. Redfield M.M., Jacobsen S.J., Burnatt J.C., et al. Burden of systolic and diastolic ventricular dysfunction in the community. JAMA 289 (2003) 194-202
3. Levy D., Kenchaiah S., Larson M.G., et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347 (2002) 1397-1402
4. Somers V.K., Dyken M.E., Mark A.L., et al. Sympathetic nervous system activity during sleep in normal subjects. N Engl J Med 328 (1993) 303-307
5. Trinder J., Kleiman J., Carrington M., et al. Autonomic activity during human sleep as a function of time and sleep stage. J Sleep Res 10 (2001) 253-264
6. Khatri I.M., and Freis E.D. Hemodynamic changes during sleep. J Appl Physiol 22 (1967) 867-873
7. Brzezinski A. Mechanisms of disease: melatonin in humans. N Engl J Med 336 (1997) 186-195
8. Knutsson A., allqvist J., Reuterwall C., et al. Shift work and myocardial infarction: a case controlled study. Occup Environ Med 56 (1999) 46-50
9. Arzt M., Young T., Finn L., et al. Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med 166 (2006) 1716-1722
10. Bergman B.M., Everson C.A., Kushida C.A., et al. Sleep deprivation in the rat, V. Energy use and mediation. Sleep 12 (1989) 31-41
11. Ayas N.T., White D.P., Manson J.E., et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med 163 (2003) 205-209
12. Kenchaiah S., Evans J.C., Levy D., et al. Obesity and the risk of heart failure. N Engl J Med 347 (2002) 305-313
13. Denke M. Treatment of the obese patient. Obesity: epidemiology, pathophysiology and prevention. N Engl J M ed 357 (2007) 2526-2527
14. Spiegel K., Tasali E., Penev P., et al. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Int Med 141 (2004) 846-850
15. Spiegel K., Leproult R., and Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 354 (1999) 1435-1439
16. Amin R.S., Kimball T.R., Bean J.A., et al. Left ventricular hypertrophy and abnormal ventricular geometry in children and adolescents with OSA. Am Respir Crit Care Med 165 (2002) 1395-1399
17. Chan J., Sanderson J., Chan W., et al. Prevalence of sleep-disordered breathing in diastolic heart failure. Chest 111 (1997) 1488-1493
18. Shahar E., Whitney C.W., Redline S., et al. Sleep disordered breathing and cardiovascular disease. Cross sectional results of the sleep heart health study. Am J Respir Crit Care Med 163 (2001) 19-25
19. Bradley T.D., Lorenzi-Filho G., and Floras J.S. Pathopysiological interactions between sleep apnea and the heart. In: Scharf S.M., Pinsky M.R., and Magder S. (Eds). Respiratory-Circulatory interactions in health and disease (2001), Marcel Dekker, New York 577-611
20. Somers V.K., Dyken M.E., Clry M.P., et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96 (1995) 1897-1904
21. Shamsuzzaman A.S., Gersh B.J., and Somers V.K. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 290 (2003) 1906-1914
22. Carlson J.T., Hedner J., Elam M., et al. Augmented resting sympathetic nerve activity in awake patients with obstructive sleep apnea. Chest 103 (1993) 1763-1768
23. Narkiewics K., and Somers V.K. Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand 177 (2003) 385-390
24. Punjabi N.M., and Beamer B.A. C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep 30 (2007) 29-34
25. Minoguchi K., Yokoe T., Tazzaki T., et al. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 172 (2005) 625-630
26. Dyugovskaya L., Lavie P., and Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165 (2002) 934-939
27. Dyugovskaya L., Lavie P., and Lavie L. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Ann N Y Acad Sci 1051 (2005) 340-350
28. Lattimore J.D., Wilcox I., Nakhla S., et al. Repetitive hypoxia increases lipid loading in human macrophages-a potentially atherogenic effect. Atherosclerosis 179 (2005) 255-259
29. Lavie L., Vishnevsky A., and Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27 (2004) 123-128
30. Li J., Savransky V., Nanayakkara A., et al. Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J Appl Physiol 102 (2007) 557-563
31. Tan K.C., Chow W.S., Lam J.C., et al. HDL dysfunction in obstructive sleep apnea. Atherosclerosis 184 (2006) 377-382
32. Kato M., Roberts-Thomson P., Phillips B.G., et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 102 (2000) 2607-2610
33. Ip M.S., Tse H.F., Lam B., et al. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 169 (2004) 348-353
34. Saravansky V, Nanayakkara A, Li J, et al., Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med. 175:1290-1297.
35. Drager L.F., Bortolotto L.A., Lorenzi M.C., et al. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172 (2005) 613-618
36. Drager L.F., Bortolotto L.A., Figueiredo A.C., et al. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 176 (2007) 706-712
37. Peppard P.E., Young T., Palta M., et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342 (2000) 1378-1384
38. Drager L.F., Bortolotto L.A., Figueiredo A.C., et al. Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest 131 (2007) 1379-1386
39. Belz G.G. Elastic properties and Windkessel function of the human aorta. Cardiovasc Drugs Ther 9 (1995) 73-83
40. Javaheri S., Parker T.J., Liming J.D., et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 97 (1998) 2154-2159
41. Solin P., Bergin P., Richardson M., et al. Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 99 (1999) 1574-1579
42. Sin D.D., Fitzgerald F., Parker J.D., et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160 (1999) 1101-1106
43. Spaak J., Egri Z.J., Kubo T., et al. Muscle sympathetic nerve activity during wakefulness in heart failure patients with and without sleep apnea. Hypertension 46 (2005) 1327-1332
44. Hall M.J., Ando S.I., Floras J.S., et al. Magnitude and time course of hemodynamic responses to Mueller maneuvers in patients with congestive heart failure. J Appl Physiol 85 (1998) 1476-1484
45. Lorenzi-Filho G., Genta P.R., et al. Cheyne-Stokes respiration in patients with congestive heart failure: causes and consequences. Clinics 60 (2005) 333-344
46. Khoo M.C., Kronauer R.E., Strohl K.P., et al. Factors inducing periodic breathing in humans: a general model. J Appl Physiol 53 (1982) 644-659
47. Carley D.W., and Shannon D.C. A minimal mathematical model of human periodic breathing. J Appl Physiol 65 (1988) 1400-1409
48. Hall M.J., Xie A., Rutherford R., et al. Cycle length of periodic breathing in patients with and without heart failure. Am J Respir Crit Care Med 154 (1996) 376-381
49. Naughton M., Benard D., Tam A., et al. Role of hyperventilation in the pathogenesis of central sleep apneas in patients with congestive heart failure. Am Rev Respir Dis 148 (1993) 330-338
50. Solin P., Roebuck T., Johns D.P., et al. Peripheral and central ventilatory responses in central sleep apnea with and without heart failure. Am J Respir Crit Care Med, 162 (2000) 2194-2200
51. Szollosi I, Thompson BR, Krum H, et al., Impaired pulmonary diffusing capacity and hypoxia in heart failure correlates with central sleep apnea severity. Chest (doi:10.1378/chest.07-1487).
52. Szollosi I., Roebuck T., Thompson B., et al. Lateral sleeping position promotes ventilatory stability in central sleep apnea/Cheyne-Stokes respiration. Sleep 29 (2006) 1045-1051
53. Lorenzi-Filho G., Rankin F., Bies I., et al. Effects of inhaled carbon dioxide and oxygen on Cheyne-Stokes respiration in patients with heart failure. Am J Respir Crit Care Med 159 (1999) 1490-1498
54. 2 to pulmonary wedge pressure in heart failure. Eur Respir J 19 (2002) 37-40
55. Roberts A.M., Bhattacharya J., Schultz H.D., et al. Stimulation of pulmonary vagal afferent C-fibres by lung edema in dogs. Circ Res 58 (1986) 512-522
56. Solin P., Snell G.I., Williams T.J., et al. Central sleep apnoea in congestive heart failure despite vagal denervation after bilateral lung transplantation. Eur Respir J 12 (1998) 495-498
57. Heistad D.D., Wheeler R.C., Mark A.L., et al. Effects of adrenergic stimulation on ventilation in man. JCI 51 (1972) 1469-1475
58. Chiu K.L., Ryan C.M., Shiota S., et al. Fluid shift by lower body positive pressure increases pharyngeal resistance in healthy subjects. Am J Respir Crit Care Med 174 (2006) 1378-1383
59. 2 and circulatory delay. Circulation 103 (2001) 238-243
60. Naughton M.T., Benard D.C., Liu P.P., et al. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 152 (1995) 473-479
61. Solin P., Kaye D.M., Little P.H.J., et al. Impact of sleep apnea on sympathetic nervous system activity in heart failure. Chest 123 (2003) 1119-1126
62. Mansfield D.R., Kaye D.M., Hans Brunner P., et al. Raised sympathetic nerve activity in heart failure and central sleep apnea is due to heart failure severity. Circulation 107 (2003) 1396-1400
63. Yusef S., Hawken S., Ounpuu S., et al. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study. Lancet 366 (2005) 1640-1649
64. Davies R.J., Ali N.J., and Stradling J.R. Neck circumference and other clinical features in the diagnosis of the obstructive sleep apnoea syndrome. Thorax 47 (1992) 101-105
65. Sjöström L., Narbro K., Sjöström C.D., et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357 (2007) 741-752
66. Adams T.D., Gress R.E., Smith S.C., et al. Long-term mortality after gastric bypass surgery. N Engl J Med 357 (2007) 753-761
67. Faccenda J.F., Mackay T.W., Boon N.A., et al. Randomised controlled trial of CPAP therapy for the sleep apnoea/hypopnoea syndrome. Am J Respir Crit Care Med 163 (2001) 344-348
68. Pepperell J.C., Ramdassingh-Dow S., et al. Ambulatory blood pressure following therapeutic and sub-therapeutic nasal CPAP for OSA: a randomised controlled parallel trial. Lancet 359 (2002) 204-210
69. Becker H.F., Jerrentrup A., Ploch T., et al. Effect of nasal CPAP treatment on blood pressure in patients with OSA. Circulation 107 (2003) 68-73
70. Campos-Rodriguez F., Perez-Ronchel J., Grilo-Reina A., et al. Long-term effect of continuous positive airway pressure on BP in patients with hypertension and sleep apnea. Chest 132 (2007) 1847-1852
71. Haentjens P., van Meerhaeghe A., Moscariello A., et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome. Arch Intern Med 167 (2007) 757-765
72. Bazzano L.A., Khan Z., Reynolds K., et al. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 50 (2007) 417-423
73. Patruno V., Aiolfi S., Costantino G., et al. Fixed and autoadjusting continuous positive airway pressure treatments are not similar in reducing cardiovascular risk factors in patients with obstructive sleep apnea. Chest 131 (2007) 1393-1399
74. Gotsopoulos H., Kelly J.J., and Cistulli P.A. Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized, controlled trial. Sleep 27 (2004) 934-941
75. Drager L.F., Bortollo L.A., Figueiredo A.C., et al. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 176 (2007) 706-712
76. Arias M.A., Garcia-Rio F., Alonso-Fernandez A., et al. Obstructive sleep apnea syndrome affects left ventricular diastolic function. Effects of nasal continuous positive airway pressure in men. Circulation 112 (2005) 375-383
77. Kaneko Y., Floras J.S., Usui K., et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348 (2003) 1233-1241
78. Mansfield D.R., Gollogly N.C., Richardson M., et al. Randomized trial of continuous positive airway treatment of obstructive sleep apnea in heart failure. Am J Respir Crit Care Med 169 (2004) 1-6
79. Wang H., Parker J.D., Newton G.E., et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 49 (2007) 1625-1631
80. Buchner N.J., Sanner B.M., Borgel J., et al. Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. Am J Respir Crit Care Med 176 (2007) 1274-1280
81. McArdle N., Devereux G., Heidarnejad H., et al. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 159 (1999) 1108-1114
82. Mansfield D.R., Solin P., Roebuck T., et al. The effect of successful heart transplant treatment of heart failure on central sleep apnea. Chest 124 (2003) 1675-1681
83. Gabor J.Y., Newman D.A., Barnard-Roberts V., et al. Improvement in Cheyne-Stokes respiration following cardiac resynchronization therapy. Eur Respir J 26 (2005) 95-100
84. Tamura A., Kawano Y., Naono S., et al. Relationship between β-blocker treatment and the severity of central sleep apnea in chronic heart failure*. Chest 131 (2007) 130-135
85. Javaheri S., Parker T.J., Wexler L., et al. Effect of theophylline on sleep disordered breathing in heart failure. N Engl J Med 335 (1996) 562-567
86. Javaheri S. Acetazolamide improves central sleep apnea in heart failure. A double blind prospective trial. Am J Respir Crit Care Med 173 (2006) 234-237
87. Khayat R.N., Xie A., Patel A.K., et al. Cardiorespiratory effects of added dead space in patients with heart failure and central sleep apnea. Chest 123 (2003) 1551-1560
88. Naughton M.T., Liu P.P., Benard D.C., et al. Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. Am J Respir Crit Care Med 151 (1995) 92-97
89. Bradley T.D., Logan A.G., Kimoff R.J., et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 353 (2005) 2025-2033
90. Arzt M., Floras J.S., Logan A.G., et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure. A post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients With Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 115 (2007) 3173-3180
91. Naughton M.T., Rahman M.A., Hara K., et al. Cardio-thoracic effects of continuous positive airway pressure in patients with heart failure. Circulation 91 (1995) 1725-1731
92. Teschler H, Döring J, Wang YM, BerthonJones M. Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. 2001;164:614-9.
93. Philippe C., Stoïca-Herman M., Drouot X., et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart 92 (2006) 337-342
94. Andreas S., Clemens C., Sandholzer H., et al. Improvement of exercise capacity with treatment of Cheyne-Stokes respiration in patients with congestive heart failure. J Am Coll Cardiol 27 (1996) 1486-1490
95. Franklin KA, Eriksson P, Sahlin C, et al: Reversal of central sleep apnea with oxygen. 111:163-169, 1997.
96. Haque W.A., Beohmer J., Clemson B.S., et al. Hemodynamic effects of supplemental oxygen administration in congestive heart failure. J Am Coll Cardiol 27 (1996) 353-357
97. Mak S., Azevedo E.R., Liu P.P., et al. Effect of hyperoxia on left ventricular function and filling pressures in patients with and without congestive heart failure. Chest 120 (2001) 467-473